1. Home
  2. CNXN vs BLDEW Comparison

CNXN vs BLDEW Comparison

Compare CNXN & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNXN
  • BLDEW
  • Stock Information
  • Founded
  • CNXN 1982
  • BLDEW N/A
  • Country
  • CNXN United States
  • BLDEW United States
  • Employees
  • CNXN N/A
  • BLDEW 281
  • Industry
  • CNXN Catalog/Specialty Distribution
  • BLDEW Transportation Services
  • Sector
  • CNXN Consumer Discretionary
  • BLDEW Consumer Discretionary
  • Exchange
  • CNXN Nasdaq
  • BLDEW Nasdaq
  • Market Cap
  • CNXN N/A
  • BLDEW N/A
  • IPO Year
  • CNXN 1998
  • BLDEW 2019
  • Fundamental
  • Price
  • CNXN $73.57
  • BLDEW $0.24
  • Analyst Decision
  • CNXN
  • BLDEW
  • Analyst Count
  • CNXN 0
  • BLDEW 0
  • Target Price
  • CNXN N/A
  • BLDEW N/A
  • AVG Volume (30 Days)
  • CNXN 123.0K
  • BLDEW N/A
  • Earning Date
  • CNXN 10-30-2024
  • BLDEW N/A
  • Dividend Yield
  • CNXN 0.54%
  • BLDEW N/A
  • EPS Growth
  • CNXN 17.07
  • BLDEW N/A
  • EPS
  • CNXN 3.35
  • BLDEW N/A
  • Revenue
  • CNXN $2,758,056,000.00
  • BLDEW N/A
  • Revenue This Year
  • CNXN $2.01
  • BLDEW N/A
  • Revenue Next Year
  • CNXN $7.29
  • BLDEW N/A
  • P/E Ratio
  • CNXN $21.97
  • BLDEW N/A
  • Revenue Growth
  • CNXN N/A
  • BLDEW N/A
  • 52 Week Low
  • CNXN $51.64
  • BLDEW N/A
  • 52 Week High
  • CNXN $77.19
  • BLDEW N/A
  • Technical
  • Relative Strength Index (RSI)
  • CNXN 52.78
  • BLDEW N/A
  • Support Level
  • CNXN $72.35
  • BLDEW N/A
  • Resistance Level
  • CNXN $77.19
  • BLDEW N/A
  • Average True Range (ATR)
  • CNXN 1.72
  • BLDEW 0.00
  • MACD
  • CNXN -0.31
  • BLDEW 0.00
  • Stochastic Oscillator
  • CNXN 25.21
  • BLDEW 0.00

About BLDEW Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: